Latest Insider Transactions at Inogen Inc (INGN)
This section provides a real-time view of insider transactions for Inogen Inc (INGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Inogen Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Inogen Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2023
|
Jason Somer EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,012
-27.84%
|
$30,180
$15.56 P/Share
|
|
Mar 01
2023
|
Jason Somer EVP, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,470
+35.84%
|
-
|
|
Mar 01
2023
|
Jason Somer EVP, Gen. Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
1,135
+30.5%
|
-
|
|
Mar 01
2023
|
Kristin A. Caltrider EVP, CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,231
-54.85%
|
$93,465
$15.56 P/Share
|
|
Mar 01
2023
|
Kristin A. Caltrider EVP, CFO and Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,360
+50.0%
|
-
|
|
Mar 01
2023
|
George J Parr Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,399
-20.29%
|
$50,985
$15.56 P/Share
|
|
Mar 01
2023
|
George J Parr Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,913
+33.04%
|
-
|
|
Mar 01
2023
|
George J Parr Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,272
+27.35%
|
-
|
|
Mar 01
2023
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,710
-23.17%
|
$55,650
$15.56 P/Share
|
|
Mar 01
2023
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,556
+32.62%
|
-
|
|
Mar 01
2023
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,272
+27.48%
|
-
|
|
Mar 01
2023
|
Nabil Shabshab CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
12,235
-16.66%
|
$183,525
$15.56 P/Share
|
|
Mar 01
2023
|
Nabil Shabshab CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
16,702
+28.52%
|
-
|
|
Mar 01
2023
|
Nabil Shabshab CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
7,810
+21.2%
|
-
|
|
Dec 01
2022
|
Nabil Shabshab CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,828
-7.93%
|
$40,216
$22.89 P/Share
|
|
Dec 01
2022
|
Nabil Shabshab CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,685
+13.78%
|
-
|
|
Dec 01
2022
|
Jason Somer EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
286
-16.47%
|
$6,292
$22.89 P/Share
|
|
Dec 01
2022
|
Jason Somer EVP, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
576
+24.9%
|
-
|
|
Dec 01
2022
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,331
-38.5%
|
$51,282
$22.89 P/Share
|
|
Dec 01
2022
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,555
+42.94%
|
-
|
|
Dec 01
2022
|
George J Parr Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
499
-11.71%
|
$10,978
$22.89 P/Share
|
|
Dec 01
2022
|
George J Parr Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,126
+20.9%
|
-
|
|
Dec 01
2022
|
Bart Ben Sanford EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
318
-3.27%
|
$6,996
$22.89 P/Share
|
|
Dec 01
2022
|
Bart Ben Sanford EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
508
+4.97%
|
-
|
|
Sep 01
2022
|
Jason Somer EVP, Gen. Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
1,145
-49.65%
|
$32,060
$28.16 P/Share
|
|
Sep 01
2022
|
Jason Somer EVP, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,306
+50.0%
|
-
|
|
Sep 01
2022
|
Bart Ben Sanford EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
318
-3.34%
|
$8,904
$28.78 P/Share
|
|
Sep 01
2022
|
Bart Ben Sanford EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
508
+5.06%
|
-
|
|
Sep 01
2022
|
George J Parr Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
499
-13.73%
|
$13,972
$28.78 P/Share
|
|
Sep 01
2022
|
George J Parr Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,126
+23.66%
|
-
|
|
Sep 01
2022
|
Nabil Shabshab CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,828
-8.62%
|
$51,184
$28.78 P/Share
|
|
Sep 01
2022
|
Nabil Shabshab CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,685
+14.81%
|
-
|
|
Sep 01
2022
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
SELL
Open market or private sale
|
Direct |
1,576
-51.25%
|
$44,128
$28.16 P/Share
|
|
Sep 01
2022
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,075
+50.0%
|
-
|
|
Jun 08
2022
|
Glenn S Boehnlein |
BUY
Grant, award, or other acquisition
|
Direct |
6,849
+48.38%
|
-
|
|
Jun 08
2022
|
Kevin M King |
BUY
Grant, award, or other acquisition
|
Direct |
6,849
+48.38%
|
-
|
|
Jun 08
2022
|
Mary Kay Ladone |
BUY
Grant, award, or other acquisition
|
Direct |
6,849
+48.38%
|
-
|
|
Jun 08
2022
|
Kristen Miranda Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,849
+38.94%
|
-
|
|
Jun 08
2022
|
Elizabeth Mora |
BUY
Grant, award, or other acquisition
|
Direct |
6,849
+41.63%
|
-
|
|
Jun 08
2022
|
Heather D. Rider |
BUY
Grant, award, or other acquisition
|
Direct |
6,849
+26.89%
|
-
|
|
Jun 01
2022
|
Nabil Shabshab CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,828
-9.45%
|
$45,700
$25.91 P/Share
|
|
Jun 01
2022
|
Nabil Shabshab CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,685
+16.0%
|
-
|
|
Jun 01
2022
|
Bart Ben Sanford EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
318
-3.41%
|
$7,950
$25.91 P/Share
|
|
Jun 01
2022
|
Bart Ben Sanford EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
508
+5.16%
|
-
|
|
Jun 01
2022
|
George J Parr Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,996
-44.32%
|
$49,900
$25.91 P/Share
|
|
Jun 01
2022
|
George J Parr Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,504
+50.0%
|
-
|
|
Mar 22
2022
|
Mary Kay Ladone |
BUY
Grant, award, or other acquisition
|
Direct |
459
+50.0%
|
-
|
|
Mar 22
2022
|
Kevin M King |
BUY
Grant, award, or other acquisition
|
Direct |
459
+50.0%
|
-
|
|
Mar 22
2022
|
Glenn S Boehnlein |
BUY
Grant, award, or other acquisition
|
Direct |
459
+50.0%
|
-
|
|
Mar 03
2022
|
Ray Benjamin M Anderson Director |
SELL
Open market or private sale
|
Indirect |
4,516
-100.0%
|
$153,544
$34.68 P/Share
|